Drug Trial Radar · NCT07005180
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Jun 30, 2026
Primary completion
Dec 31, 2026
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Hillhurst Biopharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- The Parkinson Study Group; Massachusetts General Hospital (PI: Michael Schwarzschild MD,PhD, Co-PI: Stephen Gomperts MD,PhD); Michael J. Fox Foundation for Parkinson's Research
- First posted
- Jun 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase 2a multicenter, randomized, double-blind, placebo-controlled multiple dose study to evaluate the safety, tolerability, pharmacokinetics, of HBI-002, an oral low-dose carbon monoxide (CO) liquid drug product, administered daily over 14 days in subjects with Parkinson's disease (PD).
Conditions
- Parkinson Disease
Interventions
HBI-002Drug
Oral liquid containing carbon monoxide
Vehicle (placebo)Drug
Vehicle control (placebo)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency and severity of treatment-emergent AEs related to HBI-002 compared to placebo.Time frame: From treatment to 30 days after the end of treatment
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
The Parkinson's & Movement Disorder Institute
Fountain Valley, California · Recruiting
University of Florida
Gainesville, Florida · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Not yet recruiting
University of Michigan
Ann Arbor, Michigan · Not yet recruiting
Michigan State University
East Lansing, Michigan · Not yet recruiting
Quest Research Institute
Farmington Hills, Michigan · Recruiting
Weill Cornell Medical College
New York, New York · Recruiting
Inland Northwest Research
Spokane, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.